Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference (GlobeNewswire) - Jul 25, 2024 - "Plus Therapeutics, Inc...will have multiple opportunities to present data at the 2024 Society for Neuro-Oncology (SNO) / American Society for Clinical Oncology (ASCO) CNS Metastases Conference August 8-10, in Denver, Colorado...The Company will be hosting a symposium titled, 'Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases' on August 8, 2024, at 6:15-7:15 p.m."
P1 data • Brain Cancer • Glioma • Oncology • Solid Tumor
|